Nasal Obstruction, Septal Deformity
Conditions
Keywords
Nasal obstruction, Septal deformity, Septoplasty, TnR Nasal Mesh, polycaprolactone
Brief summary
The purpose of this observation study is to evaluate long term safety and efficacy at 2\ 3 years after surgery on patients who have completed nasal septal deformity surgery using TnR Nasal Mesh.
Detailed description
Nasal obstruction is a nasal disease commonly seen in the area of otolaryngology, and major symptoms include nasal congestion, rhinitis, and etc. Nasal septoplasty is a surgery performed to improve above symptoms of nasal obstruction and so far, many surgical technique have been studied. All surgical techniques aimed to improve breathing through the nasal cavity by supporting the end of nose using surgical materials such as autologous bone or nonabsorbable material. In the case of autologous bone transplantation, safety is ensured, but there is a limitation since it causes deficiency of the donor site, and the nasal septum may be altered by a modification of the implanted tissue. In the case of nonabsorbable materials, there is a high risk of side effects such as hyposmia, septal perforation, and occurrence of boil. TnR Nasal Mesh, as a surgical material for nasal septoplasty has a sufficient flexural strength to support the nasal septum and to overcome the force of returning to a deviated state prior to surgery. Animal tests have shown that TnR Nasal mesh well supports the nasal septum after surgery and the surrounding tissue is well fused between the pores without inflammatory responses. Based on above results, a clinical trial was planned to evaluate long term safety and efficacy of TnR Nasal Mesh as a material for nasal septoplasty.
Interventions
None listed
Sponsors
T&R Biofab Co., Ltd.
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
19 Years to 74 Years
Healthy volunteers
Yes
Inclusion criteria
1. Patients who have completed nasal septal deformity surgery using TnR Nasal Mesh. 2. Females of childbearing potential must have a negative urine pregnancy test, and must not plan to become pregnant during the course of the study. 3. A person who voluntarily signed a consent form after hearing and understanding the description of this clinical study.
Exclusion criteria
1. Pregnancy or lactation * Before screening 2. History of surgery in nasal or paranasal sinuses before screening 3. History of radiation treatment at Head and neck 4. History of having participated in other clinical trial of a drug/ a medical device within three months * Screening point 5. Patients with untreated nasal bone fraction or trauma of nasal 6. Patients with surgical site infection caused by nasal bone fraction or trauma 7. Patients with inflammation in a nasal cavity 8. Patients with asthma 9. Patients with untreated a perforation of septum, a sinusitis, a nasal cavity polyposis, a nasal cavity sarcoidosis, nasal valve collapse or wegener's granulomatosis 10. Patients with sarcoma or carcinoma in a nasal cavity 11. Patients with untreated palate-facial disfigurements or cleft palate 12. Patients with sepsis 13. Patients with systemic inflammatory disease 14. Patients who are unsuitable for clinical sturdy determined by the researcher.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Total NOSE score change after surgery compared to before surgery | 1 day | The descriptive statistics(population, mean, standard deviation, median, minimum, maximun value) are presented for total NOSE score change after surgery compared to before surgery. All measurement will be completed at the time of each patient's initial visit, 1 day Total NOSE score of before surgery is based on the results of previous clinical study. The NOSE(Nasal Obstruction Symptom Evaluation) score is a 5-step scale (0(asymptomatic)-4(very severe) points) of the severity of each symptom over the past month for the 5 symptoms related to nasal obstruction (nasal hyperemia / snagging / difficulty in breathing / sleeping disorder / difficulty breathing during exercise). Then, it is evaluated by interviewing patient. The total score of 20 points is converted to 100 points and recorded. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Acoustic rhinometry results(volume) | 1 day | Changes after surgery compared to before surgery on bilateral nasal cavity volume in acoustic rhinometry result. All measurement will be completed at the time of each patient's initial visit, 1 day |
| Acoustic rhinometry results(cross sectional area) | 1 day | Changes after surgery compared to before surgery on bilateral nasal cavity cross sectional area in acoustic rhinometry result. All measurement will be completed at the time of each patient's initial visit, 1 day |
| CT images(cross sectional area) | 1 day | Changes after surgery compared to before surgery on bilateral nasal cavity cross sectional area in CT images. All measurement will be completed at the time of each patient's initial visit, 1 day |
| NOSE score change | 1 day | NOSE score change for each item after surgery compared to before. All measurement will be completed at the time of each patient's initial visit, 1 day The NOSE(Nasal Obstruction Symptom Evaluation) score is a 5-step scale (0(asymptomatic)-4(very severe) points) of the severity of each symptom over the past month for the 5 symptoms related to nasal obstruction (nasal hyperemia / snagging / difficulty in breathing / sleeping disorder / difficulty breathing during exercise). Then, it is evaluated by interviewing the patient. The total score of 20 points is converted to 100 points and recorded. |
| CT images(nasal septum angle) | 1 day | Changes after surgery compared to before surgery on nasal septum angle in CT images. All measurement will be completed at the time of each patient's initial visit, 1 day |
| Ratio of improvement of regarding symptoms after surgery | 1 day | Symptom improvement is defined as the total NOSE score reduced by more than 40 points compared to before surgery or the total NOSE score less than 20 points after surgery. All measurement will be completed at the time of each patient's initial visit, 1 day The NOSE(Nasal Obstruction Symptom Evaluation) score is a 5-step scale (0(asymptomatic)-4(very severe) points) of the severity of each symptom over the past month for the 5 symptoms related to nasal obstruction (nasal hyperemia / snagging / difficulty in breathing / sleeping disorder / difficulty breathing during exercise). Then, it is evaluated by interviewing the patient. The total score of 20 points is converted to 100 points and recorded. |
| Level of satisfaction of patients using VAS | 1 day | The patient satisfaction is evaluated using VAS(Visual Analogue Scale). All measurement will be completed at the time of each patient's initial visit, 1 day VAS(Visual Analogue Scles)Scoring and Interpretation Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the no pain anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity. |
| CT images(ratio of convex to concave side) | 1 day | Changes after surgery compared to before surgery on nasal cavity ratio of convex to concave side of cross-sectional area in CT images. All measurement will be completed at the time of each patient's initial visit, 1 day |
Contacts
Primary ContactJeongmin Choi, pm
Outcome results
None listed